168 TLR7-VGLL3 synergism potentiates lupus-like autoimmunity in mice
Journal of Investigative Dermatology2023Vol. 143(5), pp. S28–S28
O. Plazyo, K. Young, Allison C. Billi, M. Gharaee-Kermani, R. Wasikowski, L. Tsoi, J.M. Kahlenberg, J. Gudjonsson
Related Papers
- → A novel Toll-like receptor 7/8–specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus(2023)19 cited
- → PO.1.1 Afimetoran, a potent and selective inhibitor of human toll-like receptor 7 (TLR7) and tlr8, provides robust efficacy in a murine lupus model of advanced disease(2022)4 cited
- → Identification of U11snRNA as an endogenous agonist of TLR7-mediated immune pathogenesis(2019)19 cited
- → PATHOPHYSIOLOGY OF DRUG-INDUCED LUPUS(2004)2 cited
- → Precise determination of toll-like receptor (TLR) 7 expression in multiple human tumor types(2014)